---
layout: post
title: The Future of Pharma in the UK
date: '2012-02-03T08:41:00.002Z'
author: John Overington
tags: 
modified_time: '2012-02-03T08:41:45.206Z'
thumbnail: http://4.bp.blogspot.com/-0LT7XdnlQoo/TyubOAQ0g0I/AAAAAAAABgw/uXDtBWWoBac/s72-c/AstraZeneca-lg.jpg
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-1198084298799981971
blogger_orig_url: http://chembl.blogspot.com/2012/02/future-of-pharma-in-uk.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-0LT7XdnlQoo/TyubOAQ0g0I/AAAAAAAABgw/uXDtBWWoBac/s1600/AstraZeneca-lg.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://4.bp.blogspot.com/-0LT7XdnlQoo/TyubOAQ0g0I/AAAAAAAABgw/uXDtBWWoBac/s320/AstraZeneca-lg.jpg" width="320" /></a></div>
<br />
It has been difficult to avoid the news of the continuous downsizing of Pharma, and to those in the UK this has been especially painful recently. There is an excellent opinion piece <a href="http://onenucleus.wordpress.com/2012/01/05/what-is-the-future-for-drug-discovery-in-the-uk/">here</a>, written by <a href="http://en.wikipedia.org/wiki/Simon_Campbell">Simon Campbell</a>, ex-head of R&amp;D at Pfizer, and also ex-President of the Royal Society of Chemistry. It was also interesting to &nbsp;<a href="http://www.bbc.co.uk/news/business-16849634">see some of the comment</a>s from <a href="http://en.wikipedia.org/wiki/David_Phillips_(chemist)">David Phillips</a> (the current President of the of the Royal Society of Chemistry)&nbsp;that...<br />
<br />
<quote>"the easy targets for new drugs... in the body... essentially have all been used up"<quote></quote></quote><br />
<quote><br /></quote><br />
<quote>This is a major interest of ours, as regular readers will know; so expect a post on that exact subject soon.</quote>